Mayo Clinic income dips in 2022 after facing higher labor and supply expenses
Fierce Healthcare
FEBRUARY 27, 2023
Mayo Clinic income dips in 2022 after facing higher labor and supply expenses rking Mon, 02/27/2023 - 15:19
Mayo Clinic Related Topics 
115 
Mayo Clinic, K Health team up to use AI for personalized hypertension treatment
Fierce Healthcare
JUNE 19, 2022
Mayo Clinic, K Health team up to use AI for personalized hypertension treatment. hlandi. Sun, 06/19/2022 - 19:00
Join 24,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Mayo Clinic launches AI startup program to help early-stage companies get market-ready
Fierce Healthcare
MARCH 24, 2022
Mayo Clinic launches AI startup program to help early-stage companies get market-ready. hlandi. Thu, 03/24/2022 - 15:47
How Google, Mayo Clinic and Kaiser Permanente tackle AI bias and thorny data privacy problems
Fierce Healthcare
SEPTEMBER 28, 2022
How Google, Mayo Clinic and Kaiser Permanente tackle AI bias and thorny data privacy problems. dmuoio. Tue, 09/27/2022 - 17:35
Alphabet's Verily, Mayo Clinic team up on decision support tech for cardiovascular care
Fierce Healthcare
AUGUST 26, 2021
Alphabet's Verily, Mayo Clinic team up on decision support tech for cardiovascular care. hlandi. Thu, 08/26/2021 - 09:08
Mayo Clinic posts $227M operating loss for Q1 as labor expenses shoot up
Fierce Healthcare
MAY 20, 2022
Mayo Clinic posts $227M operating loss for Q1 as labor expenses shoot up. rking. Fri, 05/20/2022 - 13:24
Mayo Clinic retains top hospital title while other big names shuffle throughout U.S. News' top 20
Fierce Healthcare
JULY 26, 2022
Mayo Clinic retains top hospital title while other big names shuffle throughout U.S. News' top 20. dmuoio. Tue, 07/26/2022 - 15:01
Mayo Clinic, Mercy's new collaboration will mine years of deidentified patient data for clinical insights
Fierce Healthcare
JULY 25, 2022
Mayo Clinic, Mercy's new collaboration will mine years of deidentified patient data for clinical insights. dmuoio. Mon, 07/25/2022 - 16:09
Mayo Clinic's steady volume recovery draws $324M net operating income, $4B revenue for Q3
Fierce Healthcare
NOVEMBER 19, 2021
Mayo Clinic's steady volume recovery draws $324M net operating income, $4B revenue for Q3. dmuoio. Fri, 11/19/2021 - 12:03
Data privacy solution TripleBlind secures $24M backed by General Catalyst, Mayo Clinic
Fierce Healthcare
OCTOBER 20, 2021
Data privacy solution TripleBlind secures $24M backed by General Catalyst, Mayo Clinic. hlandi. Wed, 10/20/2021 - 09:22
Mayo Clinic Study: Diets Higher in Calcium, Potassium Help Prevent Kidney Stones
Pharmacy Times
AUGUST 8, 2022
Unlike prior recommendations for prevention, which focus on dietary factors associated with first-time stone formulation, the new analysis looks at recurrences.
Castle Creek Biosciences Collaborates with Mayo Clinic to Expand Gene Therapy Platform
Pharma Mirror
OCTOBER 26, 2021
a clinical-stage cell and gene therapy company focused on developing and commercializing disease-modifying therapies for patients suffering from rare diseases for which there is a lack of available treatment options, has formed a new research collaboration with Mayo Clinic.
Mayo Clinic's operating margin holds firm at 3.8% as slumping investments fuel $654M net loss for Q2 2022
Fierce Healthcare
AUGUST 19, 2022
Mayo Clinic's operating margin holds firm at 3.8% as slumping investments fuel $654M net loss for Q2 2022. dmuoio. Fri, 08/19/2022 - 11:54
Neuroglee, Mayo Clinic partner on remote care management for Alzheimer’s
Outsourcing Pharma
SEPTEMBER 9, 2021
The digital therapeutics firm's Neuroglee Connect remote care platform and virtual clinic is for patients with mild cognitive impairment, including Alzheimerâs. Clinical Development
Expert Discusses PD-1 Inhibitors as Treatment of NSCLC
Pharmacy Times
DECEMBER 4, 2022
Scott Soefje, director of Pharmacy Cancer Care and assistant professor of Pharmacy at Mayo Clinic, discusses PD-1 inhibitors and its use in non–small cell lung cancer.
HLTH 2022 – Day 3
Pharma Phorum
NOVEMBER 16, 2022
That will include a presentation by Oracle Health, digital health celebrity John Halamka of the Mayo Clinic, and a stacked panel on “Clinical Trials and Tribulations” featuring representatives from AbbVie, Walgreens, Optum, and Scripps Research.
Startup Neuroglee raises $10m for virtual neurology clinics
Pharma Phorum
SEPTEMBER 10, 2021
A digital health company focusing on neurodegenerative disorders – Neuroglee Therapeutics – has raised $10 million in first-round funding to roll out a virtual neurology clinics for people with cognitive problems caused by dementia.
What Can Supplements Really Do For Health and Beauty?
Pharma Mirror
DECEMBER 4, 2020
According to Mayo Clinic, the benefits of supplements specifically apply to pregnant people (subject to doctor’s recommendation), over the age of 50, who have food allergies or digestive conditions or miss large food groups in their diet.
AI-powered stethoscope from Eko spots heart failure in seconds
Pharma Phorum
FEBRUARY 1, 2022
Eko’s ECG-enabled stethoscope – dubbed the DUO ECG + Digital Stethoscope – was put through its paces in more than 1,000 patients who were attending NHS clinics at seven sites in London, including Imperial College Healthcare NHS Trust (ICHNT) hospitals – for standard 12-lead ECG monitoring.
Amazon bolsters Alexa’s health credentials with Sharecare deal
Pharma Phorum
SEPTEMBER 21, 2020
Amazon already has a number of alliances with providers for healthcare content, and last year agreed a contract with the UK’s National Health Service (NHS), having also previously sourced information from the likes of the Mayo Clinic, WebMD and Cigna.
False positives with Apple Watch could tie up health resources
Pharma Phorum
SEPTEMBER 29, 2020
A study of people who consulted a doctor after an abnormal pulse was detected by their device suggests it could lead to false positives that mean unnecessary healthcare visits, according to the team from the Mayo Clinic.
Innovation in targeted therapies: Leading companies in photodynamic cancer therapy drugs
Pharmaceutical Technology
MARCH 14, 2023
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, and the gravity of unmet needs, as well as the growing importance of technologies such as pharmacogenomics, digital therapeutics, and artificial intelligence.
The antimicrobial pipeline is ‘dry’ and that’s a problem
Pharma Phorum
MAY 11, 2022
According to the Mayo Clinic , the overuse of antibiotics sees around one-third of people taking the treatments when they are neither needed nor appropriate. The work of CARB-X is necessary because, in the words of The WHO, “the clinical pipeline of new antimicrobials is dry.”
VMLY&Rx appoints Nichole Davies as global chief strategy officer
Pharma Phorum
MARCH 29, 2021
Throughout her career she has worked with industry leaders including AstraZeneca, Pfizer, Lilly, Sanofi, GSK, Johnson & Johnson, Janssen, Merck, Genentech, and the Mayo Clinic.
Eyeing emergency use of COVID-19 drug, Humanigen partners with Lonza to make it
Pharma Phorum
SEPTEMBER 15, 2020
In June, Mayo Clinic researchers announced data on the first clinical use of lenzilumab in 12 patients with severe and critical COVID-19 pneumonia, saying that the majority showed rapid recovery and discharge from hospital.
Double resignation over Aduhelm approval depletes FDA’s CNS adcomm
Pharma Phorum
JUNE 10, 2021
Washington University neurologist Joel Perlmutter was the first to announce he was stepping down from the Peripheral and Central Nervous System Drugs Advisory Committee on the day after the approval, and he was joined yesterday by Mayo Clinic neurologist David Knopman.
Innovation in chemotherapy: Leading companies in platinum-based cancer drug compositions
Pharmaceutical Technology
MARCH 14, 2023
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, and the gravity of unmet needs, as well as the growing importance of technologies such as pharmacogenomics, digital therapeutics, and artificial intelligence.
Civica plans shake-up of insulin sector with low-cost biosimilars
Pharma Phorum
MARCH 3, 2022
First launched in 2018 to to tackle shortages in lifesaving medicines and improve the affordability of drugs, Civica has now teamed up with a consortium of US health systems and other stakeholders, including Kaiser Permanente, Intermountain Healthcare, and the Mayo Clinic, on the insulin project.
Trials leave Galapagos’ SIK programme looking under the weather
Pharma Phorum
JULY 16, 2021
Galapagos has had to send its SIK inhibitor programme back to the drawing board after its lead compound GLPG3970 has failed two of three clinical trials, adding to a string of disappointments for the Belgian biotech. .
ASH roundup: late breakers take the stage
Pharma Phorum
DECEMBER 14, 2022
At ASH, the E1910 clinical trial generated results could unlock a new patient population for Blincyto, after it was shown to improve overall survival in patients with no measurable residual disease (MRD) after induction chemotherapy for B-ALL.
Blockchain: Ready to revolutionise medicinal cannabis research?
Pharma Phorum
JUNE 29, 2021
Robert Galarza outlines how blockchain technology can be utilised to verify, validate and standardise the efficacy of medical cannabis and other plant based therapies in clinical trials. . “Clinical research depends on more than just the science of cannabis and how it affects the body.
Building the hospital of the future
Pharma Phorum
JUNE 15, 2021
As Mark Wehde, Chair, Mayo Clinic Division of Engineering, explains: “Healthcare is shifting from a traditional hospital?centric Every patient, every doctor or nurse, every hospital worker is a human being influenced by their experiences outside of healthcare.
The invisible burden of RSV on older adults
Pharma Phorum
DECEMBER 15, 2022
Due to the similar nature of RSV’s symptoms compared to other respiratory diseases, the only way to definitively diagnose the virus is through clinical testing. Mayo Clinic. Cleveland Clinic.
Trials and tribulations in Biogen’s Alzheimer’s drug reviews
Pharma Phorum
NOVEMBER 3, 2020
The paper in the journal Alzheimer’s & Dementia, led by Mayo Clinic neurologist David Knopman, says that efficacy of aducanumab “as a treatment for the cognitive dysfunction in Alzheimer’s disease cannot be proven by clinical trials with divergent outcomes.”.
Industry group says FDA botched COVID-19 convalescent plasma guidance
Pharma Phorum
AUGUST 27, 2020
The preprint data referred to is a Mayo Clinic study used to support the EUA based on data taken from patients treated with plasma under the Expanded Access Programme.
Ep. 005 – Dave Chase Podcast Transcript
Pharma Marketing Network
JUNE 8, 2020
You better get people to a Virginia Mason or a Mayo Clinic or things like that. I mean Mayo Clinic, they found about 20% misdiagnosis. Don (PMN): Hi welcome. This is Don Langsdorf with the Pharma Marketing Network pleased to welcome today Dave Chase, co-founder of the Health Rosetta. Good morning, Dave. Thanks for coming on the podcast and if you wouldn’t mind, could tell us a little bit about yourself. Dave (HR): Sure. Thanks for having me on.
Let's personalize your content